These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27071377)

  • 1. Hypoxia-inducible factor 1 in autoimmune diseases.
    Deng W; Feng X; Li X; Wang D; Sun L
    Cell Immunol; 2016 May; 303():7-15. PubMed ID: 27071377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.
    Olson N; van der Vliet A
    Nitric Oxide; 2011 Aug; 25(2):125-37. PubMed ID: 21199675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.
    Islam SMT; Won J; Khan M; Mannie MD; Singh I
    Immunology; 2021 Sep; 164(1):31-42. PubMed ID: 33813735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypoxia-inducible factor (HIF) couples immunity with metabolism.
    Halligan DN; Murphy SJ; Taylor CT
    Semin Immunol; 2016 Oct; 28(5):469-477. PubMed ID: 27717536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases.
    Guan SY; Leng RX; Tao JH; Li XP; Ye DQ; Olsen N; Zheng SG; Pan HF
    Expert Opin Ther Targets; 2017 Jul; 21(7):715-723. PubMed ID: 28553732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor 1 in lower limb ischemia.
    Ho TK; Abraham DJ; Black CM; Baker DM
    Vascular; 2006; 14(6):321-7. PubMed ID: 17150152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease.
    Hirota SA; Beck PL; MacDonald JA
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jan; 3(1):1-16. PubMed ID: 19149741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and hypoxia signaling in tissue repair and fibrosis.
    Lokmic Z; Musyoka J; Hewitson TD; Darby IA
    Int Rev Cell Mol Biol; 2012; 296():139-85. PubMed ID: 22559939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HIF in immunity and inflammation.
    Cummins EP; Keogh CE; Crean D; Taylor CT
    Mol Aspects Med; 2016; 47-48():24-34. PubMed ID: 26768963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target.
    Zhan L; Huang C; Meng XM; Song Y; Wu XQ; Yang Y; Li J
    Biochimie; 2015 Jan; 108():1-7. PubMed ID: 25447141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors.
    Probst-Cousin S; Neundörfer B; Heuss D
    Neuromuscul Disord; 2010 Mar; 20(3):192-7. PubMed ID: 20122829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease.
    Liu J; Wei Q; Guo C; Dong G; Liu Y; Tang C; Dong Z
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the HIF pathway in inflammation and immunity.
    Scholz CC; Taylor CT
    Curr Opin Pharmacol; 2013 Aug; 13(4):646-53. PubMed ID: 23660374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of hypoxia-inducible factor-1α in inflammatory autoimmune diseases: A comprehensive review.
    Tang YY; Wang DC; Wang YQ; Huang AF; Xu WD
    Front Immunol; 2022; 13():1073971. PubMed ID: 36761171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factors in T lymphocyte differentiation and function. A Review in the Theme: Cellular Responses to Hypoxia.
    Tao JH; Barbi J; Pan F
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C580-9. PubMed ID: 26354751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers.
    Catrina SB; Zheng X
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():179-85. PubMed ID: 26453314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between HIF-1 and AP-1 transcription factors in response to low oxygen.
    Laderoute KR
    Semin Cell Dev Biol; 2005; 16(4-5):502-13. PubMed ID: 16144688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
    Mizukami Y; Kohgo Y; Chung DC
    Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1: a key mediator in hypoxia.
    Adams JM; Difazio LT; Rolandelli RH; Luján JJ; Haskó G; Csóka B; Selmeczy Z; Németh ZH
    Acta Physiol Hung; 2009 Mar; 96(1):19-28. PubMed ID: 19264039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.